Health & Life Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022
Share
Health & Life Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 241.54 million compared to TWD 174.39 million a year ago. Net income was TWD 7.77 million compared to net loss of TWD 22.16 million a year ago. Basic earnings per share from continuing operations was TWD 0.16 compared to basic loss per share from continuing operations of TWD 0.47 a year ago. Diluted earnings per share from continuing operations was TWD 0.16 compared to diluted loss per share from continuing operations of TWD 0.47 a year ago.
For the nine months, sales was TWD 568.87 million compared to TWD 582.26 million a year ago. Net loss was TWD 3.35 million compared to TWD 29.39 million a year ago. Basic loss per share from continuing operations was TWD 0.07 compared to TWD 0.62 a year ago. Diluted loss per share from continuing operations was TWD 0.07 compared to TWD 0.62 a year ago.
Health & Life Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of medical equipment. The Company's mainly provides electronic sphygmomanometers, such as blood pressure monitors, nebulizers and blood glucose monitoring systems, which are used to measure and record systolic and diastolic blood pressure and glucose of human beings. The Company distributes its products within domestic market and to overseas markets.
HEALTH & LIFE CO., LTD. 
